AU2001292773A1 - Expression, preparation, uses, and sequence of recombinantly-derived soluble hla-g - Google Patents
Expression, preparation, uses, and sequence of recombinantly-derived soluble hla-gInfo
- Publication number
- AU2001292773A1 AU2001292773A1 AU2001292773A AU9277301A AU2001292773A1 AU 2001292773 A1 AU2001292773 A1 AU 2001292773A1 AU 2001292773 A AU2001292773 A AU 2001292773A AU 9277301 A AU9277301 A AU 9277301A AU 2001292773 A1 AU2001292773 A1 AU 2001292773A1
- Authority
- AU
- Australia
- Prior art keywords
- recombinantly
- expression
- sequence
- preparation
- soluble hla
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23276100P | 2000-09-15 | 2000-09-15 | |
US60232761 | 2000-09-15 | ||
PCT/US2001/029228 WO2002022784A2 (fr) | 2000-09-15 | 2001-09-17 | Expression, preparation, utilisations et sequence de la proteine hla-g soluble derivee par recombinaison |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001292773A1 true AU2001292773A1 (en) | 2002-03-26 |
Family
ID=22874459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001292773A Abandoned AU2001292773A1 (en) | 2000-09-15 | 2001-09-17 | Expression, preparation, uses, and sequence of recombinantly-derived soluble hla-g |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1328290A2 (fr) |
AU (1) | AU2001292773A1 (fr) |
CA (1) | CA2425186A1 (fr) |
WO (1) | WO2002022784A2 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007011044A1 (fr) * | 2005-07-15 | 2007-01-25 | Kyushu University, National University Corporation | Composition pharmaceutique comprenant un dimere hla-g lie disulfide et procede de fabrication de ce dimere hla-g lie disulfide |
EP2184297A1 (fr) * | 2008-11-07 | 2010-05-12 | Hla-G Technologies | Polypeptides HLA-G et leurs utilisations pharmaceutiques |
EP2264067A1 (fr) * | 2009-06-18 | 2010-12-22 | Hla-G Technologies | Multimères de HLA-G alpha 1 et leurs utilisations pharmaceutiques |
JP2012530106A (ja) * | 2009-06-18 | 2012-11-29 | エイチエルエイ−ジー・テクノロジーズ | HLA−Gα1多量体及びその薬学的使用 |
EP2730588A1 (fr) * | 2012-11-12 | 2014-05-14 | Intelectys | Anticorps et fragments de ceux-ci dirigés contre le domaine alpha-3 de protéine HLA-G, procédés et moyens pour leur préparation et leurs utilisations |
TW201829463A (zh) | 2016-11-18 | 2018-08-16 | 瑞士商赫孚孟拉羅股份公司 | 抗hla-g抗體及其用途 |
PE20211767A1 (es) | 2018-09-27 | 2021-09-07 | Tizona Therapeutics | Anticuerpos anti-hla-g, composiciones que comprenden anticuerpos anti-hla-g y metodos de uso de anticuerpos anti-hla-g |
-
2001
- 2001-09-17 WO PCT/US2001/029228 patent/WO2002022784A2/fr not_active Application Discontinuation
- 2001-09-17 EP EP01973167A patent/EP1328290A2/fr not_active Ceased
- 2001-09-17 AU AU2001292773A patent/AU2001292773A1/en not_active Abandoned
- 2001-09-17 CA CA002425186A patent/CA2425186A1/fr not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002022784A3 (fr) | 2002-06-06 |
EP1328290A2 (fr) | 2003-07-23 |
WO2002022784A2 (fr) | 2002-03-21 |
CA2425186A1 (fr) | 2002-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002217226A1 (en) | Methanesulphonamido-benzofuran, preparation method and use thereof as synthesis intermediate | |
HUP0300527A3 (en) | Pyrrolopyrimidinone derivatives, process of preparation and use | |
AU2001240753A1 (en) | Lipid nanocapsules, preparation method and use as medicine | |
AU2002235128A1 (en) | Expression miniarrays and uses thereof | |
AU7429100A (en) | Chondrocyte compositions, preparation and use thereof | |
AU2001237526A1 (en) | Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof | |
AU2001248279A1 (en) | New compounds, their preparation and use | |
AU2268301A (en) | Novel urea compounds, compositions and methods of use and preparation | |
AU4549499A (en) | Polyurea-based adhesives, articles therefrom, and methods of their preparation and use | |
AU2002359126A1 (en) | Benzodiazepine derivatives, preparation thereof and use thereof | |
AU2001286701A1 (en) | Hyaluronan-based antiadhesion compositions, their preparation and use | |
AU2002359123A1 (en) | Benzodiazepine derivatives, preparation thereof and use thereof | |
WO2002036145A8 (fr) | Kahalalide f | |
AU2002241508A1 (en) | Membrane derived caspase-3, compositions comprising the same and methods of use therefor | |
AU5886500A (en) | Indolyl-benzimidazole antibacterials, and methods of use thereof | |
AU2002243392A1 (en) | Immunogenic proteoliposomes, and uses thereof | |
AU2001292773A1 (en) | Expression, preparation, uses, and sequence of recombinantly-derived soluble hla-g | |
AU2000254308A1 (en) | Pyrazolopyrimidinone derivatives, process for their preparation and their use | |
AU5368699A (en) | Derivatives of triptolide, and preparation and uses thereof | |
AU2001241771A1 (en) | Use of avocado-soybean unsaponifiable preparations | |
AU3883800A (en) | Hob-bp2h compositions, methods and uses thereof | |
AU2001264863A1 (en) | Preparation of fagopyritols and uses therefor | |
AU2001234616A1 (en) | Vaccine composition, process and methods | |
AU2001284084A1 (en) | Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof | |
AU2002246585A1 (en) | Plant promoters, and methods of use |